59 reports

INDUSTRY COMPETITION- MODERATE ##.

  • Diabetes
  • HIV AIDS
  • North America
  • World
  • Becton Property Group

The revenue in 2017 decreased by approximately ##%, as compared to 2016.

  • HIV AIDS
  • Therapy
  • World
  • Market Size
  • Merck & Co., Inc.

" One of the amazing things about working at UCLA is that for each of the targeted diseases, we collaborate with leading clinicians who already have gene therapies in development, Weiss said.

  • Cancer
  • HIV AIDS
  • Medical Biotechnology
  • Therapy
  • United States
  • APR 05, 2017: NIDA ANNOUNCES RECIPIENTS OF 2017 AVANT-GARDE AWARDS FOR HIV/AIDS RESEARCH

The winning proposals focus on a variety of novel approaches, including: improving HIV prevention through effective gene therapies; enhancing innate (natural) immunity against HIV and other related viruses; and developing new small-molecule drugs to treat HIV-## infection.

  • HIV AIDS
  • Opioid
  • United States
  • Lightlake Therapeutics Inc.
  • Opiant Pharmaceuticals, Inc.

You can easily book an appointment with one online.

  • HIV AIDS
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

VBL Therapeutics' adenoviral gene therapy VB-## (ofranergene obadenovec) selectively induces TNFR## expression in tumor vasculature, resulting in tumor starvation.

  • HIV AIDS
  • United States
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

Gilead and GlaxoSmithKline Plc. ##.

  • HIV AIDS
  • World
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • HIV Development Pipeline, by Phase
  • PIPELINE OVERVIEW

She is a co-inventor on many issued US patents and applications related to projects on cell and gene therapies.

  • HIV AIDS
  • United States
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • ViiV Healthcare Ltd.
  • 8.7 PROGRESS TOWARDS A FUNCTIONAL CURE
  • 8.5 SAFE AND EFFICACIOUS THERAPIES FOR PATIENTS WITH DRUG-RESISTANT HIV STRAINS

THESE INCLUDE GENE THERAPY TO ALTER THE IMMUNE SYSTEM OF INFECTED PATIENTS AND CREATE IMMUNITY AGAINST HIV.

  • HIV AIDS
  • East Asia
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • ViiV Healthcare Ltd.
  • HBV
  • 4.4.2.2 Clinical Trial Duration by Molecule Type and Stage of Development

Gene Therapy for Acquired Immune-Deficiency Syndrome (HIV) Gene Therapy for Hepatitis B and Hepatitis C Gene Therapy for HSV-## Eye Infections Gene Therapy to Inhibit Gag for HIV-## Infection Gene Therapy to Target HIV-## DNA for H

  • HIV AIDS
  • Infectious Disease
  • Therapy
  • Market Size
  • Gilead Sciences, Inc.

## or NR##C##) ## ## ## ## ## HIV ## p## ## ## ## ## ## Free Radical ## ## ## ## ## P##X Purinoceptor ## (P##Z Receptor or P##RX##) ## ## ## ## ## Prostaglandin G/ H Synthase ## (Cyclooxygenase ## or COX## or Prostaglandin Endoperoxide Sy

  • HIV AIDS
  • Therapy
  • Italy
  • Supply
  • Medestea

Elvitegravir is an inhibitor of HIV-## integrase.

  • HIV AIDS
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson

One unit refers to one PAC.

  • Catheter
  • Clinical Trial
  • HIV AIDS
  • Hospital
  • Edwards Lifesciences Corporation
  • FEB 14, 2019: AMERICAN GENE TECHNOLOGIES SIGNS RESEARCH AGREEMENT WITH NIAID FOR EXPERIMENTAL HIV/AIDS CURE STRATEGY
  • Dormant Products, H1 2019 (Contd..1), H1 2019

The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ##, ## and ## respectively.

  • HIV AIDS
  • Medical Biotechnology
  • United States
  • World
  • CytoDyn Inc.

Alpha-## antitrypsin deficiency, or " alpha-##, is a single gene disorder.

  • Gene Therapy
  • Healthcare
  • HIV AIDS
  • Therapy
  • United States
  • AIDS - RELATED LYMPHOMA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018*

The prominent features of this report are - ##.

  • HIV AIDS
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • F. Hoffmann-La Roche Ltd.

" CAR-T cell therapy is one of the first forms of gene therapy in cancer and one of the most impressive new tools in immunotherapy.

  • HIV AIDS
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Gilead Sciences, Inc.
  • Dec 19, 2017: FIT Biotech's FIT-06 phase 1 HIV clinical trial results published

FIT BIOTECH OY' S ANNUAL FINANCIAL REPORT JANUARY ##- DECEMBER ##, 2016 Mar ##, 2017: Fit Biotech Oy' s Half-year Financial Report January ##-December ##, 2016 (unaudited) Main events January-December 2016: Research projects in gene therapy and the treatment of HIV h

  • Biotechnology
  • HIV AIDS
  • Finland
  • Company
  • Beijing Minhai

Herceptin (+##%).

  • HIV AIDS
  • United States
  • Company
  • Demand
  • Roche Group

At the recent meeting, Humbert' s talk was one of eight from Kiem' s group and his collaborators in Fred Hutch' s Stem Cell and Gene Therapy Program, which Kiem directs.

  • Cancer
  • HIV AIDS
  • Specialty Hospital
  • United States
  • Juno Therapeutics Inc.
  • AIDS - RELATED CANCER THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018*

The prominent features of this report are - ##.

  • HIV AIDS
  • Lymphoma
  • Medical Biotechnology
  • World
  • Product Initiative

Jonah Sacha, Ph. D., is associate professor at OHSU and has appointments in the Vaccine & Gene Therapy Institute and Oregon National Primate Research Center.

  • HIV AIDS
  • Pharmaceutical
  • United States
  • Product Initiative
  • CytoDyn Inc.
  • OTHER SIGNIFICANT DEVELOPMENTS
  • NOV 09, 2017: GEOVAX REPORTS 2017 THIRD QUARTER FINANCIAL RESULTS AND DEVELOPMENT PROGRAM UPDATES

(AGT) for use of our vaccine in combination with AGT' s gene therapy for development of a functional cure for HIV is on track to enter a Phase ## trial sponsored by AGT.

  • HIV AIDS
  • Vaccine
  • United States
  • Company
  • GeoVax Labs, Inc.

Release ##, ##-##.

  • Clinical Trial
  • HIV AIDS
  • Pharmaceutical
  • United States
  • AcelRx Pharmaceuticals, Inc.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Celgene Corp ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Jo

  • Cancer
  • HIV AIDS
  • United States
  • World
  • Product Initiative

SANOFI ALSO HAS ONE OF THE INDUSTRY' S LARGEST RESEARCH PROGRAMS IN THE FIELD OF GENE THERAPY AND CLINICAL TRIALS IN AGE-RELATED MACULAR DEGENERATION AND PARKINSON' S DISEASE.

  • HIV AIDS
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Mylan Inc.
  • Pfizer Inc.

a cell and gene therapy software and analytics platform company, to create a software solution to support commercial availability of T-cell therapies.

  • Hepatitis
  • HIV AIDS
  • United States
  • Corporate Finance
  • Gilead Sciences, Inc.

The prominent features of this report are - ##.

  • Cancer
  • Clinical Trial
  • HIV AIDS
  • Oncology
  • Merck & Co., Inc.

UniQure NV (UniQure) develops and markets gene therapy products.

  • HIV AIDS
  • Medical Biotechnology
  • United States
  • Company
  • Bristol-Myers Squibb Company

## ## ## ## ## ## Russia ## ## ## ## ## ## ## ## Turkey ## ## ## ## ## ## ## ## Brazil ## ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## ## India ## ## ## ## ## ## ## ## Source: GlobalData' s Pharma Intelligence Center Cli

  • Cancer
  • HIV AIDS
  • United States
  • World
  • Product Initiative